FDA Inspection 1202190 — Koligo Therapeutics Inc
The FDA completed an inspection of Koligo Therapeutics Inc on February 28, 2023 in New Albany, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 28, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- New Albany, IN (United States)